Wednesday, February 10, 2010, 1:55PM AEST - The Australian Stockmarket closes in 2 hours and 10 minutes.
To create a watchlist or portfolio of shares, Register

NeuroMetrix Inc. (NURO)

7:59AM AEST: 2.242 USD  Up 0.052 (2.37%)  
 MORE ON NURO 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 NeuroMetrix, Inc. (NGM:NURO) Delayed quote dataEdit
Last Trade:2.242 USD
Trade Time: 7:59AM AEST
Change:Up 0.052 (2.37%)
Prev Close:2.19
Open:2.23
Bid:2.03 x 100
Ask:N/A
1y Target Est:4.30
Day's Range:2.10 - 2.30
52wk Range:1.11 - 3.60
Volume:23,783
Avg Vol (3m):34,184.1
Market Cap:51.48M
P/E (ttm):N/A
EPS (ttm):-1.135
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add NURO to Portfolio   Download Data

 HEADLINES 
NeuroMetrix, Inc. Announces Date for 2009 Financial Results Conference Call
Business Wire (Thu, Feb 4)
NEUROMETRIX, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Fri, Jan 1)
NeuroMetrix Ready for Public Sale
Zacks.com (Tue, Dec 29)
Neurometrix registers shares, hints at possible hedge fund exit
at bizjournals.com (Tue, Dec 22)
Court Dismisses NeuroMetrix Lawsuit
Zacks.com (Fri, Dec 18)
NEUROMETRIX, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Dec 15)
Federal Court Dismisses Securities Class Action Lawsuit Against NeuroMetrix, Inc.
Business Wire (Tue, Dec 15)
NEUROMETRIX, INC. Financials
EDGAR Online Financials (Wed, Nov 18)
NEUROMETRIX, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
NeuroMetrix, Inc. Earnings Call scheduled for 8:00 am ET today
CCBN (Fri, Nov 6)
NEUROMETRIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
EDGAR Online (Thu, Nov 5)
NEUROMETRIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Wed, Sep 16)
More Headlines for NURO...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.84
EPS Est (in 2 years) (Dec-10) :-0.39
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
NeuroMetrix, Inc., a medical device company, engages in the development and commercialization of products that aid physicians in the assessment, treatment, and repair of peripheral nerve and spinal cord injuries and disorders, and that provide reg...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices